Biotronik said it inked a deal to provide cardiac rhythm management devices to the 8 million veterans served by the U.S. Veterans Affairs Dept.
The Berlin-based company makes cardiac resynchronization therapy defibrillators and endovascular medical devices.
“We are honored and excited to bring our portfolio of devices to support the men and women who have served in America’s military services, as well as their families. We strive to create the best quality products with clinically meaningful innovation, and provide them for the best cost possible. We are thrilled to be included in this contract,” Biotronik executive vice president of sales Paul Woodstock said in prepared remarks.
Biotronik won CE Mark approval in the European Union for its PK Papyrus coronary stent system in November 2013 for treating acute coronary artery perforation.